Jordi Canes
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial.
Journal: ESMO open
Published: June 05, 2025
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 27, 2024
Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity.
Journal: EMBO molecular medicine
Published: October 10, 2024
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Journal: Frontiers in oncology
Published: January 26, 2023
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Journal: Future oncology (London, England)
Published: October 06, 2022
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Journal: Cancer treatment reviews
Published: February 15, 2022
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
Journal: Frontiers in oncology
Published: July 19, 2021
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
Journal: NPJ breast cancer
Published: March 13, 2021
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Journal: Future oncology (London, England)
Published: July 08, 2020
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 11, 2020
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Journal: Breast cancer research : BCR
Published: February 16, 2019
Last Updated: 09/26/2026